Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Koehler

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
ACS Medicinal Chemistry Letters|June 22, 2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8Philippe Bergeron, Michael F T Koehler, Elizabeth M Blackwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.
Journal of Medicinal Chemistry|March 12, 2013
Pyrimidoaminotropanes as potent, selective, and efficacious small molecule kinase inhibitors of the mammalian target of rapamycin (mTOR)Anthony A Estrada, Daniel G Shore, Elizabeth Blackwood, et al.
Journal of Medicinal Chemistry|March 4, 2011
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activityBrad E Sleebs, Peter E Czabotar, Wayne J Fairbrother, et al.
Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.
Mbio|September 8, 2016
A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal PeptidaseJ Hiroshi Morisaki, Peter A Smith, Shailesh V Date, et al.
Journal of Medicinal Chemistry|April 19, 2011
Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidineFrederick Cohen, Philippe Bergeron, Elizabeth Blackwood, et al.
Mbio|June 1, 2021
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic ConjugateKimberly K Kajihara, Homer Pantua, Hilda Hernandez-Barry, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2018
Disrupting Gram-Negative Bacterial Outer Membrane Biosynthesis through Inhibition of the Lipopolysaccharide Transporter MsbAMary Kate Alexander, Anh Miu, Angela Oh, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|June 22, 2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8Philippe Bergeron, Michael F T Koehler, Elizabeth M Blackwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.
Journal of Medicinal Chemistry|March 12, 2013
Pyrimidoaminotropanes as potent, selective, and efficacious small molecule kinase inhibitors of the mammalian target of rapamycin (mTOR)Anthony A Estrada, Daniel G Shore, Elizabeth Blackwood, et al.
Journal of Medicinal Chemistry|March 4, 2011
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activityBrad E Sleebs, Peter E Czabotar, Wayne J Fairbrother, et al.
Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.
Mbio|September 8, 2016
A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal PeptidaseJ Hiroshi Morisaki, Peter A Smith, Shailesh V Date, et al.
Journal of Medicinal Chemistry|April 19, 2011
Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidineFrederick Cohen, Philippe Bergeron, Elizabeth Blackwood, et al.
Mbio|June 1, 2021
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic ConjugateKimberly K Kajihara, Homer Pantua, Hilda Hernandez-Barry, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2018
Disrupting Gram-Negative Bacterial Outer Membrane Biosynthesis through Inhibition of the Lipopolysaccharide Transporter MsbAMary Kate Alexander, Anh Miu, Angela Oh, et al.
Pageof 7